Misha Luyer
Papers
34
Total Citations
1,271
H-Index
20
About
Misha Luyer is a leading surgical oncologist whose research has fundamentally shaped the adoption and standardization of minimally invasive pancreatic surgery. His work centers on comparing laparoscopic, robotic, and open approaches to complex pancreatic resections — particularly pancreatoduodenectomy and distal pancreatectomy — with a focus on patient outcomes, oncological safety, and surgical training. Luyer's most influential contributions include landmark multicenter randomized controlled trials such as the DIPLOMA and LEOPARD series, which have provided rigorous evidence on the feasibility, cost-effectiveness, and quality-of-life benefits of minimally invasive techniques. His 2018 outcomes study on minimally invasive versus open pancreatoduodenectomy (159 citations) and the 2023 DIPLOMA non-inferiority trial (121 citations) have become essential references in pancreatic surgery literature. Equally notable is his LAELAPS-3 program (118 citations), which demonstrated that structured multicenter training in robotic pancreatoduodenectomy is both safe and reproducible, helping to democratize access to advanced surgical techniques beyond pioneering centers. With contributions to internationally validated European guidelines and learning curve analyses across 635 robotic procedures, Luyer's cumulative body of work — exceeding 750 citations across these ten papers alone — has had a measurable, practice-changing impact on hepatopancreatic surgery worldwide.
Research Focus
Key Achievements
Top Papers
- 1Outcomes After Minimally-invasive Versus Open Pancreatoduodenectomy159 citations · 2018
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10